Henry Schein Inc (HSIC)

Industry Medical Distribution

This stock can be held in an Investment ISA and an Investment Account

Sell

$75.74

Buy

$77.35

arrow-up$0.31 (+0.41%)

Prices updated at 12 Dec 2025, 23:36 EST

Prices minimum 15 mins delay

Prices in USD

Henry Schein Inc is a provider of healthcare products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Distribution

Chairman

Mr. Stanley M. Bergman

CEO

Mr. Stanley M. Bergman

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

25,000

Head office

135 Duryea Road

Melville

United States

11747

+1 631 843-5500

carolynne.borders@henryschein.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Stanley M. Bergman Chairman of the Board and Chief Executive Officer	1.69m
Mr. William K. Daniel Independent Director	-
Mr. Robert J. Hombach Independent Director	-
Mr. Max C. Lin Independent Director	-
Dr. Bradley T. Sheares, PhD Independent Director	0.14m
Ms. Deborah M. Derby Independent Director	0.14m
Mr. Joseph L. Herring Independent Director	0.17m
Mr. Kurt P. Kuehn Independent Director	0.16m
Mr. Philip A. Laskawy Lead Independent Director	0.17m
Mr. Walter Siegel Senior Vice President and Chief Legal Officer	-
Dr. Reed V. Tuckson, M.D. Independent Director	0.11m
Mr. Michael S. Ettinger Executive Vice President and Chief Operating Officer	0.73m
Mr. Mohamad Ali Independent Director	0.12m
Ms. Anne H. Margulies Independent Director	0.14m
Mr. Christopher Pendergast Senior Vice President and Chief Technology Officer	-
Mr. James Mullins Senior Vice President, Global Supply Chain	-
Mr. Scott P. Serota Independent Director	0.12m
Ms. Carole T. Faig Independent Director	0.11m
Mr. Ronald N. South Senior Vice President, Principal Accounting Officer and Chief Financial Officer	0.63m
Mr. Andrea Albertini Chief Executive Officer, Global Distribution and Technology	-
Ms. Kelly Murphy Senior Vice President and General Counsel	-
Mr. Tom Popeck Chief Executive Officer, Henry Schein Products Group	-
Mr. R. Steven Boggan Co-Chief Executive Officer, Global Oral Reconstruction Group	-
Ms. Christine Sheehy Senior Vice President and Chief Human Resources Officer	-
Ms. Bianka Wilson Co-Chief Executive Officer, Global Oral Reconstruction Group	-
Mr. David Kochman Senior Vice President and Chief Corporate Affairs Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Kohlberg Kravis Roberts & Co LP	15,652,032
Vanguard Group Inc	12,931,701
JPMorgan Chase & Co	12,417,540
Artisan Partners Limited Partnership	6,833,041
BlackRock Inc	6,676,650

Director dealings

Date chevron-l-regular chevron-r-regular	Action
19 Dec 2024	-
11 Dec 2024	-
18 Nov 2024	-
16 Sep 2024	-
06 Sep 2024	-
14 Aug 2024	-
09 Aug 2024	-
07 Jun 2024	-
06 Jun 2024	-
14 May 2024	-
20 Mar 2024	-
20 Mar 2024	-
18 Mar 2024	-
09 Mar 2024	-
09 Mar 2024	-
09 Mar 2024	-
09 Mar 2024	-
06 Mar 2024	-
05 Mar 2024	-
04 Mar 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.